-+ 0.00%
-+ 0.00%
-+ 0.00%

HSBC Maintains Hold on Pfizer, Raises Price Target to $30

Benzinga·09/10/2026 13:40:10
语音播报
HSBC analyst Rajesh Kumar maintains Pfizer (NYSE:PFE) with a Hold and raises the price target from $28 to $30.